Dimensional Fund Advisors LP Century Therapeutics, Inc. Transaction History
Dimensional Fund Advisors LP
- $403 Billion
- Q3 2024
A detailed history of Dimensional Fund Advisors LP transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 33,449 shares of IPSC stock, worth $30,438. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,449
Previous 75,315
55.59%
Holding current value
$30,438
Previous $192,000
70.31%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IPSC
# of Institutions
66Shares Held
36.9MCall Options Held
8.7KPut Options Held
10.2K-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$4.92 Million1.66% of portfolio
-
Vr Adviser, LLC New York, NY5.39MShares$4.9 Million0.95% of portfolio
-
Boxer Capital, LLC San Diego, CA3.9MShares$3.55 Million0.35% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$2.92 Million0.43% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$2.64 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $53.6M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...